Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Foundation Medicine Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Foundation Medicine Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Foundation Medicine Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Foundation Medicine Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Foundation Medicine Inc, Medical Devices Deals, 2012 to YTD 2018 10
Foundation Medicine Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Foundation Medicine Inc, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
Foundation Medicine Secures USD42.5 Million In Series B Financing 13
Partnerships 15
Incyte and Foundation Medicine Enter into Agreement 15
Bristol-Myers Squibb Enters into Agreement with Foundation Medicine 16
Foundation Medicine Enters into Agreement with Sarah Cannon Research Institute 17
Epizyme Enters into Agreement with Foundation Medicine 18
Foundation Medicine Enters into Agreement with AstraZeneca 19
Foundation Medicine Partners with AstraZeneca 20
Foundation Medicine Enters into Agreement with Mirati Therapeutics 21
Foundation Medicine Extends its Co-Development Agreement with H3 Biomedicine 22
Roche Amends R&D Agreement with Foundation Medicine 23
Foundation Medicine Enters into Co-Development Agreement with Flatiron Health 24
Foundation Medicine Enters Into Distribution Agreement With Laboratorios Leti 25
Foundation Medicine Enters Into Agreement With Agios Pharma To Develop Cancer Diagnostics 26
Foundation Medicine Enters Into Agreement With AstraZeneca For Genomic Profiling 27
Foundation Medicine Enters Into Agreement With Eisai For Genomic Profiling And Diagnostic Discovery 28
Foundation Medicine Enters Into Co-Development Agreement With Sanofi For Genetic Biomarkers And Potential Diagnostics 29
Equity Offering 30
Foundation Medicine Raises USD250 Million in Private Placement of Shares 30
Foundation Medicine Withdraws Public Offering Of Shares For Up To US$150 Million 31
Foundation Medicine Completes IPO Of Shares For US$122 Million 32
Acquisition 34
Roche to Acquire Remaining Stake in Foundation Medicine for USD2.4 Billion 34
Roche Acquires Majority Stake in Foundation Medicine for USD1.03 Billion 35
Foundation Medicine Inc – Key Competitors 37
Foundation Medicine Inc – Key Employees 38
Foundation Medicine Inc – Locations And Subsidiaries 39
Head Office 39
Other Locations & Subsidiaries 39
Recent Developments 40
Financial Announcements 40
Mar 07, 2018: Foundation Medicine Announces 2017 Fourth Quarter and Year-End Results, Recent Highlights and 2018 Outlook 40
Jan 08, 2018: Foundation Medicine Reports Preliminary 2017 Results 42
Nov 01, 2017: Foundation Medicine Announces 2017 Third Quarter Results and Recent Highlights 44
Aug 01, 2017: Foundation Medicine Announces 2017 Second Quarter Results and Recent Highlights 45
May 09, 2017: Foundation Medicine Announces 2017 First Quarter Results and Recent Highlights 47
Feb 22, 2017: Foundation Medicine Announces 2016 Fourth Quarter and Year-End Results, Recent Highlights and 2017 Outlook 49
Jan 09, 2017: Foundation Medicine Reports Preliminary 2016 Results 50
Corporate Communications 52
Jul 26, 2018: Chugai Pharmaceutical announces organizational and personnel changes 52
Oct 10, 2017: Foundation Medicine Appoints Tom Civik as Chief Commercial Officer 53
Jan 06, 2017: Foundation Medicine Announces Executive Leadership Transition 54
Legal and Regulatory 55
Jul 18, 2018: Foundation Medicine and Guardant Health Agree to Settle Patent Infringement Lawsuit 55
Mar 13, 2018: Foundation Medicine and Guardant Health Agree to Resolve False Advertising Lawsuit 56
Government and Public Interest 57
May 14, 2018: Genetic fixer-uppers may help predict bladder cancer prognosis 57
Product News 59
Dec 06, 2017: The Leukemia & Lymphoma Society Achieves New Milestones in Offensive Against Acute Myeloid Leukemia, Deadly Blood Cancer 59
Other Significant Developments 61
May 02, 2018: Foundation Medicine launches gene expression profiling program to identify known and novel biomarkers in advanced cancer 61
Appendix 62
Methodology 62
About GlobalData 62
Contact Us 62
Disclaimer 62
Foundation Medicine Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Foundation Medicine Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Foundation Medicine Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Foundation Medicine Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Foundation Medicine Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Foundation Medicine Inc, Medical Devices Deals, 2012 to YTD 2018 10
Foundation Medicine Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Foundation Medicine Secures USD42.5 Million In Series B Financing 13
Incyte and Foundation Medicine Enter into Agreement 15
Bristol-Myers Squibb Enters into Agreement with Foundation Medicine 16
Foundation Medicine Enters into Agreement with Sarah Cannon Research Institute 17
Epizyme Enters into Agreement with Foundation Medicine 18
Foundation Medicine Enters into Agreement with AstraZeneca 19
Foundation Medicine Partners with AstraZeneca 20
Foundation Medicine Enters into Agreement with Mirati Therapeutics 21
Foundation Medicine Extends its Co-Development Agreement with H3 Biomedicine 22
Roche Amends R&D Agreement with Foundation Medicine 23
Foundation Medicine Enters into Co-Development Agreement with Flatiron Health 24
Foundation Medicine Enters Into Distribution Agreement With Laboratorios Leti 25
Foundation Medicine Enters Into Agreement With Agios Pharma To Develop Cancer Diagnostics 26
Foundation Medicine Enters Into Agreement With AstraZeneca For Genomic Profiling 27
Foundation Medicine Enters Into Agreement With Eisai For Genomic Profiling And Diagnostic Discovery 28
Foundation Medicine Enters Into Co-Development Agreement With Sanofi For Genetic Biomarkers And Potential Diagnostics 29
Foundation Medicine Raises USD250 Million in Private Placement of Shares 30
Foundation Medicine Withdraws Public Offering Of Shares For Up To US$150 Million 31
Foundation Medicine Completes IPO Of Shares For US$122 Million 32
Roche to Acquire Remaining Stake in Foundation Medicine for USD2.4 Billion 34
Roche Acquires Majority Stake in Foundation Medicine for USD1.03 Billion 35
Foundation Medicine Inc, Key Competitors 37
Foundation Medicine Inc, Key Employees 38
Foundation Medicine Inc, Other Locations 39
List of Figures
Foundation Medicine Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Foundation Medicine Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Foundation Medicine Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Foundation Medicine Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Foundation Medicine Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Foundation Medicine Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Foundation Medicine Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Foundation Medicine Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Foundation Medicine Inc, Medical Devices Deals, 2012 to YTD 2018 10